Report Update Nov 1, 2024

Republic of Korea - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report

Sent by email within 24h (Mon-Fri)

$599 Basic Edition

$2095 Professional Edition

What's the difference?

Subscription

Online access and download

from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Republic of Korea: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in Republic of Korea

After two years of decline, the South Korean medicaments containing insulin market increased by 20% to $X in 2021. Overall, consumption enjoyed a strong increase. Over the period under review, the market hit record highs at $X in 2018; however, from 2019 to 2021, consumption remained at a lower figure.

Medicaments Containing Insulin Production in Republic of Korea

In value terms, medicaments containing insulin production dropped to $X in 2021 estimated in export price. Overall, production saw a strong expansion. The pace of growth appeared the most rapid in 2017 with an increase of 34%. Over the period under review, production hit record highs at $X in 2020, and then shrank slightly in the following year.

Medicaments Containing Insulin Exports

Exports from Republic of Korea

In 2019, medicaments containing insulin exports from South Korea totaled X kg, stabilizing at 2018 figures. Overall, exports recorded a significant contraction. The pace of growth appeared the most rapid in 2014 when exports increased by 988% against the previous year. As a result, the exports attained the peak of X tons. From 2015 to 2019, the growth of the exports remained at a lower figure.

In value terms, medicaments containing insulin exports stood at $X in 2019. In general, exports saw a deep downturn. The most prominent rate of growth was recorded in 2014 when exports increased by 873% against the previous year. As a result, the exports attained the peak of $X. From 2015 to 2019, the growth of the exports remained at a lower figure.

Exports by Country

Denmark (X kg) was the main destination for medicaments containing insulin exports from South Korea, with a approx. 100% share of total exports.

From 2012 to 2019, the average annual rate of growth in terms of volume to Denmark was relatively modest.

From 2012 to 2019, the average annual rate of growth in terms of value to Denmark was relatively modest.

Export Prices by Country

In 2019, the average medicaments containing insulin export price amounted to $X per ton, standing approx. at the previous year. Overall, the export price enjoyed significant growth. The growth pace was the most rapid in 2018 when the average export price increased by 82% against the previous year. Over the period under review, the average export prices hit record highs in 2019 and is expected to retain growth in years to come.

As there is only one major export destination, the average price level is determined by prices for Denmark.

From 2012 to 2019, the rate of growth in terms of prices for Panama amounted to -15.9% per year.

Medicaments Containing Insulin Imports

Imports into Republic of Korea

After five years of decline, purchases abroad of medicaments containing insulin but not antibiotics increased by 144% to X kg in 2021. Over the period under review, imports continue to indicate buoyant growth. The growth pace was the most rapid in 2014 when imports increased by 524% against the previous year. Imports peaked at X tons in 2015; however, from 2016 to 2021, imports failed to regain momentum.

In value terms, medicaments containing insulin imports skyrocketed to $X in 2021. Overall, imports showed significant growth. The growth pace was the most rapid in 2014 when imports increased by 322%. Over the period under review, imports reached the maximum in 2021 and are expected to retain growth in the immediate term.

Imports by Country

In 2021, the United States (X kg) was the main medicaments containing insulin supplier to South Korea, with a 96% share of total imports. It was followed by China (X kg), with a 1.9% share of total imports.

From 2012 to 2021, the average annual rate of growth in terms of volume from the United States stood at +15.4%. The remaining supplying countries recorded the following average annual rates of imports growth: China (-7.9% per year) and Canada (+27.7% per year).

In value terms, the United States ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to South Korea, comprising 96% of total imports. The second position in the ranking was held by China ($X), with a 3.4% share of total imports.

From 2012 to 2021, the average annual growth rate of value from the United States stood at +59.1%. The remaining supplying countries recorded the following average annual rates of imports growth: China (+115.3% per year) and Canada (+36.1% per year).

Import Prices by Country

The average medicaments containing insulin import price stood at $X per ton in 2021, growing by 6.3% against the previous year. Overall, the import price recorded significant growth. The pace of growth was the most pronounced in 2020 when the average import price increased by 411%. The import price peaked in 2021 and is likely to see gradual growth in the near future.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was China ($X per ton), while the price for Canada ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by China (+59.5%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing insulin but not antibiotics in the world?

Denmark constituted the country with the largest volume of medicaments containing insulin consumption, accounting for 58% of total volume. Moreover, medicaments containing insulin consumption in Denmark exceeded the figures recorded by the second-largest consumer, the U.S., sevenfold. The third position in this ranking was occupied by Pakistan, with a 3.6% share.

What are the largest producers of medicaments containing insulin but not antibiotics in the world?

The country with the largest volume of medicaments containing insulin production was the U.S., accounting for 80% of total volume. Moreover, medicaments containing insulin production in the U.S. exceeded the figures recorded by the second-largest producer, Denmark, more than tenfold. The third position in this ranking was occupied by Pakistan, with a 2.5% share.

What are the leading suppliers of medicaments containing insulin but not antibiotics to Republic of Korea?

In value terms, the U.S. $2) constituted the largest supplier of medicaments containing insulin to South Korea.

What is the average export price for medicaments containing insulin but not antibiotics in Republic of Korea?

The average medicaments containing insulin export price stood at $47,311 per ton in 2019, falling by -8.6% against the previous year.

What is the average import price for medicaments containing insulin but not antibiotics in Republic of Korea?

The average medicaments containing insulin import price stood at $2,047 per ton in 2020, shrinking by -97% against the previous year.

This report provides an in-depth analysis of the medicaments containing insulin market in Republic of Korea. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

South Korea

Data coverage:

Market volume and value
Per Capita consumption
Forecast of the market dynamics in the medium term
Trade (exports and imports) in Republic of Korea
Export and import prices
Market trends, drivers and restraints
Key market players and their profiles

Reasons to buy this report:

Take advantage of the latest data
Find deeper insights into current market developments
Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

How to diversify your business and benefit from new market opportunities
How to load your idle production capacity
How to boost your sales on overseas markets
How to increase your profit margins
How to make your supply chain more sustainable
How to reduce your production and supply chain costs
How to outsource production to other countries
How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business
1. REPORT DESCRIPTION
2. RESEARCH METHODOLOGY AND AI PLATFORM
3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
4. GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance
1. KEY FINDINGS
2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects
1. MARKET SIZE
2. MARKET STRUCTURE
3. TRADE BALANCE
4. PER CAPITA CONSUMPTION
5. MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO
1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
2. BEST-SELLING PRODUCTS
3. MOST CONSUMED PRODUCT
4. MOST TRADED PRODUCT
5. MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO
1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
2. TOP PRODUCING COUNTRIES
3. TOP EXPORTING COUNTRIES
4. LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO
1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
2. TOP CONSUMING MARKETS
3. UNSATURATED MARKETS
4. TOP IMPORTING MARKETS
5. MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry
1. PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
1. IMPORTS FROM 2012–2023
2. IMPORTS BY COUNTRY
3. IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
1. EXPORTS FROM 2012–2023
2. EXPORTS BY COUNTRY
3. EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO
LIST OF TABLES
1. Key Findings In 2023
2. Market Volume, In Physical Terms, 2012–2023
3. Market Value, 2012–2023
4. Per Capita Consumption In 2012-2023
5. Imports, In Physical Terms, By Country, 2012–2023
6. Imports, In Value Terms, By Country, 2012–2023
7. Import Prices, By Country Of Origin, 2012–2023
8. Exports, In Physical Terms, By Country, 2012–2023
9. Exports, In Value Terms, By Country, 2012–2023
10. Export Prices, By Country Of Destination, 2012–2023
LIST OF FIGURES
1. Market Volume, In Physical Terms, 2012–2023
2. Market Value, 2012–2023
3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
5. Trade Balance, In Physical Terms, 2012-2023
6. Trade Balance, In Value Terms, 2012-2023
7. Per Capita Consumption, 2012-2023
8. Market Volume Forecast to 2030
9. Market Value Forecast to 2030
10. Products: Market Size And Growth, By Type
11. Products: Average Per Capita Consumption, By Type
12. Products: Exports And Growth, By Type
13. Products: Export Prices And Growth, By Type
14. Production Volume And Growth
15. Exports And Growth
16. Export Prices And Growth
17. Market Size And Growth
18. Per Capita Consumption
19. Imports And Growth
20. Import Prices
21. Production, In Physical Terms, 2012–2023
22. Production, In Value Terms, 2012–2023
23. Imports, In Physical Terms, 2012–2023
24. Imports, In Value Terms, 2012–2023
25. Imports, In Physical Terms, By Country, 2023
26. Imports, In Physical Terms, By Country, 2012–2023
27. Imports, In Value Terms, By Country, 2012–2023
28. Import Prices, By Country Of Origin, 2012–2023
29. Exports, In Physical Terms, 2012–2023
30. Exports, In Value Terms, 2012–2023
31. Exports, In Physical Terms, By Country, 2023
32. Exports, In Physical Terms, By Country, 2012–2023
33. Exports, In Value Terms, By Country, 2012–2023
34. Export Prices, By Country Of Destination, 2012–2023